Vernal keratoconjunctivitis: Evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia

Clinical and Experimental Allergy

Volumn 33, Issue 3, 2003, Pages 279-281

  Ono, S J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN E;

ALLERGIC REACTION; ATOPY; CLINICAL FEATURE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; EFFECTOR CELL; EOSINOPHIL; EOSINOPHILIA; EYE DISEASE; GENETIC LINKAGE; GENOME; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TH2 CELL; VERNAL CONJUNCTIVITIS;

CONJUNCTIVITIS, ALLERGIC; EOSINOPHILIA; HUMANS; IMMUNOGLOBULIN E; KERATOCONJUNCTIVITIS;

EID: 0037337454     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2745.2003.01616.x     Document Type: Editorial

References (16)

1. Liu G, Keane-Myers A, Miyazaki D, Tai KF, Ono SJ. Hypersensitivity reactions in the conjunctiva. Chem Immunol 1999; 73:39-58.
2. Toda M, Ono SJ. Genomics and Proteomics of Allergic Disease. Immunology 2002 May; 106:1-10.
3. Casolaro V, Georas SN, Song Z, Ono SJ. Biology and genetics of atopic disease. Current Opinion Immunol 1996; 8:6.
4. Ono SJ. Genetics of atopic disease. Annu Rev Immunol 2000; 18:347-66.
5. Nishimura A, Campbell-Meltzer RS, Chute K, Orell J, Ono SJ. Genetics of allergic disease: evidence for organ-specific susceptibility genes. Int Arch Allergy Immunol 2001; 124:197-200.
6. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995; 50:610-3.
7. Pucci N, Novembre E, Lombardi E et al. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms. Clin Exp Allergy 2003; 33:325-30.
8. Leckie MJ, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and late asthmatic response. Lancet 2000; 356:2144-8.
9. Hogan SP, Foster PS, Rothenberg ME. Experimental analysis of eosinophil-associated gastrointestinal diseases. Current Opinion Allergy Clin Immunology 2002; 2:239-48.
10. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002; 169:4604-12.
11. Miyazaki D, Liu G, Clark LA, Ono SJ. Prevention of acute allergic conjunctivitis and late phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Visual Sci 2000; 41:3850-5.
12. Keane-Myers AM, Miyazaki D, Liu G, Dekaris I, Ono SJ, Dana RM. Treatment with IL-1 receptor antagonist prevents allergic eye disease. Invest Ophthalmol Visual Sci 1999; 40:3041-6.
13. Menzies-Gov A, Ying S, Sabroe I et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils and macrophages as well as features of early and late phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 2002; 169:2712-8.
14. Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, Colston MJ. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transriptomic and proteomic approach. Immunology 2001; 104:99-108.
15. Beaulieu S, Du Robbiani DFX, Rodrigues E et al. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells. J Immunol 2002; 169:2925-36.
16. Nakajima T, Inagaki N, Tanaka H et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fc epsilon receptor I cross-linking: an interspecies comparison. Blood 2002; 100:3861-8.